A Northwestern Medicine study has shed light on a critical molecular mechanism underlying amyotrophic lateral sclerosis (ALS) ...
PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach for treating Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig’s ...
Additionally, NDC-011, a novel drug combination developed through DR.NOAH's AI-based drug discovery platform, received Orphan Drug Designation (ODD) from the U.S. FDA in 2023 and IND approval for a ...
The FDA has cleared the initiation of a pivotal Phase 3 trial testing pridopidine in people with early, rapidly progressive ...
Researchers have developed a novel approach to detect ALS and predict survival by measuring genetic activity in blood cells, a study found.
PRESS RELEASEAB SCIENCE ANNOUNCES NEW PUBLICATION ON MEDRXIV HIGHLIGHTING CLINICAL BENEFIT WITH MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS ...
Wave Life Sciences Ltd is a pioneering force in genetic medicine, focusing on creating innovative treatments for serious ...
The news comes eight months after Dane shared in an exclusive statement to PEOPLE that he has been diagnosed with amyotrophic ...
Eric Dane's efforts to raise awareness about amyotrophic lateral sclerosis (ALS) continue with a memoir about his condition.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback